Alere Inc. Reports Employment Inducement Awards Pursuant to NYSE Rule 303A.08

WALTHAM, Mass., April 6, 2015 /PRNewswire/ -- Alere Inc. (NYSE: ALR), a global leader in rapid diagnostics, announced today, pursuant to NYSE Rule 303A.08, that it has granted, or will grant, employment inducement awards to James Hinrichs, the Company's new Executive Vice President and Chief Financial Officer, as part of his previously disclosed compensation package. On March 23, 2015, the Company announced the appointment of Mr. Hinrichs to serve as its new Executive Vice President and Chief Financial Officer effective April 6, 2015.

As of April 6, 2015, Mr. Hinrichs was granted an option to purchase 250,000 shares of Alere common stock, and an additional award of 50,000 restricted stock units, each unit representing the right to acquire one share of Alere common stock, will be granted after a registration statement on Form S-8 covering the shares issuable under awards has been filed with the Securities and Exchange Commission. The awards were granted as an employment inducement award outside of Alere Inc.'s current shareholder approved stock options and incentive plans pursuant to NYSE Rule 303A.08. For the further details regarding Mr. Hinrichs' employment and compensation, please see the Company's Current Report on Form 8-K filed March 23, 2015 with the Securities and Exchange Commission.

About AlereBecause Knowing now matters™, Alere delivers reliable and actionable information through rapid diagnostic tests, resulting in better clinical and economic healthcare outcomes globally. Headquartered in Waltham, Mass., Alere focuses on rapid diagnostics for infectious disease, cardiometabolic disease and toxicology. For more information on Alere, please visit www.alere.com.

To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/alere-inc-reports-employment-inducement-awards-pursuant-to-nyse-rule-303a08-300061340.html

SOURCE Alere Inc.